Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance...

Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells

Andrew J. Rech, Robert H. Vonderheide
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1174
Year:
2009
Language:
english
Pages:
8
DOI:
10.1111/j.1749-6632.2009.04939.x
File:
PDF, 177 KB
english, 2009
Conversion to is in progress
Conversion to is failed